170 related articles for article (PubMed ID: 11077068)
1. Role of AMPA and GluR5 kainate receptors in the development and expression of amygdala kindling in the mouse.
Rogawski MA; Kurzman PS; Yamaguchi SI; Li H
Neuropharmacology; 2001; 40(1):28-35. PubMed ID: 11077068
[TBL] [Abstract][Full Text] [Related]
2. Interaction of GYKI 52466, a selective non-competitive antagonist of AMPA/kainate receptors, with conventional antiepileptic drugs in amygdala-kindled seizures in rats.
Borowicz KK; Duda AM; Kleinrok Z; Czuczwar SJ
Pol J Pharmacol; 2001; 53(2):101-8. PubMed ID: 11787948
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo studies in rats with LY293558 suggest AMPA/kainate receptor blockade as a novel potential mechanism for the therapeutic treatment of anxiety disorders.
Alt A; Weiss B; Ogden AM; Li X; Gleason SD; Calligaro DO; Bleakman D; Witkin JM
Psychopharmacology (Berl); 2006 Apr; 185(2):240-7. PubMed ID: 16470401
[TBL] [Abstract][Full Text] [Related]
4. The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures.
Dürmüller N; Craggs M; Meldrum BS
Epilepsy Res; 1994 Feb; 17(2):167-74. PubMed ID: 8194512
[TBL] [Abstract][Full Text] [Related]
5. GluR5 kainate receptor mediated synaptic transmission in rat basolateral amygdala in vitro.
Li H; Rogawski MA
Neuropharmacology; 1998; 37(10-11):1279-86. PubMed ID: 9849665
[TBL] [Abstract][Full Text] [Related]
6. Selective protection against AMPA- and kainate-evoked neurotoxicity by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisoquinoline- 3-carboxylic acid (LY293558) and its racemate (LY215490).
Schoepp DD; Salhoff CR; Fuson KS; Sacaan AI; Tizzano JP; Ornstein PL; May PC
J Neural Transm (Vienna); 1996; 103(8-9):905-16. PubMed ID: 9013384
[TBL] [Abstract][Full Text] [Related]
7. Effects of decahydroisoquinoline-3-carboxylic acid monohydrate, a novel AMPA receptor antagonist, on glutamate-induced CA2+ responses and neurotoxicity in rat cortical and cerebellar granule neurons.
Liljequist S; Cebers G; Kalda A
Biochem Pharmacol; 1995 Nov; 50(11):1761-74. PubMed ID: 8615854
[TBL] [Abstract][Full Text] [Related]
8. Kainate receptor-mediated activation of the AP-1 transcription factor complex in cultured rat cerebellar granule cells.
Kovács AD; Cebers G; Liljequist S
Brain Res Bull; 2000 May; 52(2):127-33. PubMed ID: 10808083
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid.
Bleakman R; Schoepp DD; Ballyk B; Bufton H; Sharpe EF; Thomas K; Ornstein PL; Kamboj RK
Mol Pharmacol; 1996 Apr; 49(4):581-5. PubMed ID: 8609884
[TBL] [Abstract][Full Text] [Related]
10. The GluK1 (GluR5) Kainate/{alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist LY293558 reduces soman-induced seizures and neuropathology.
Figueiredo TH; Qashu F; Apland JP; Aroniadou-Anderjaska V; Souza AP; Braga MF
J Pharmacol Exp Ther; 2011 Feb; 336(2):303-12. PubMed ID: 20962029
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of the GluK1/AMPA receptor antagonist LY293558 against seizures and neuropathology in a soman-exposure model without pretreatment and its pharmacokinetics after intramuscular administration.
Apland JP; Aroniadou-Anderjaska V; Figueiredo TH; Green CE; Swezey R; Yang C; Qashu F; Braga MF
J Pharmacol Exp Ther; 2013 Jan; 344(1):133-40. PubMed ID: 23042954
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antagonism of AMPA receptor activation by (3S, 4aR, 6R, 8aR)-6-[2-(1(2)H-tetrazole-5-yl) ethyl] decahydroisoquinoline-3-carboxylic acid.
Schoepp DD; Lodge D; Bleakman D; Leander JD; Tizzano JP; Wright RA; Palmer AJ; Salhoff CR; Ornstein PL
Neuropharmacology; 1995 Sep; 34(9):1159-68. PubMed ID: 8532186
[TBL] [Abstract][Full Text] [Related]
13. Locomotor activity detects subunit-selective effects of agonists and decahydroisoquinoline antagonists at AMPA/kainic acid ionotropic glutamate receptors in adult rats.
O'neill MF; Sanger G; Ornstein PL; Osborne DJ; Woodhouse SM
Psychopharmacology (Berl); 2005 Apr; 179(1):181-8. PubMed ID: 15821949
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo.
Weiss B; Alt A; Ogden AM; Gates M; Dieckman DK; Clemens-Smith A; Ho KH; Jarvie K; Rizkalla G; Wright RA; Calligaro DO; Schoepp D; Mattiuz EL; Stratford RE; Johnson B; Salhoff C; Katofiasc M; Phebus LA; Schenck K; Cohen M; Filla SA; Ornstein PL; Johnson KW; Bleakman D
J Pharmacol Exp Ther; 2006 Aug; 318(2):772-81. PubMed ID: 16690725
[TBL] [Abstract][Full Text] [Related]
15. Effects of YM90K, a selective AMPA receptor antagonist, on amygdala-kindling and long-term hippocampal potentiation in the rat.
Kodama M; Yamada N; Sato K; Kitamura Y; Koyama F; Sato T; Morimoto K; Kuroda S
Eur J Pharmacol; 1999 Jun; 374(1):11-9. PubMed ID: 10422635
[TBL] [Abstract][Full Text] [Related]
16. Actions of kainate and AMPA selective glutamate receptor ligands on nociceptive processing in the spinal cord.
Procter MJ; Houghton AK; Faber ES; Chizh BA; Ornstein PL; Lodge D; Headley PM
Neuropharmacology; 1998; 37(10-11):1287-97. PubMed ID: 9849666
[TBL] [Abstract][Full Text] [Related]
17. Non-N-methyl-D-aspartate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity.
Donevan SD; Yamaguchi S; Rogawski MA
J Pharmacol Exp Ther; 1994 Oct; 271(1):25-9. PubMed ID: 7525924
[TBL] [Abstract][Full Text] [Related]
18. Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines.
Wilding TJ; Huettner JE
Mol Pharmacol; 1995 Mar; 47(3):582-7. PubMed ID: 7700255
[TBL] [Abstract][Full Text] [Related]
19. Facilitation of amygdala kindling development and kindled seizures by metaphit.
Chen NH; Wang C; Jobe PC; Reith ME
Epilepsia; 1994; 35(5):927-32. PubMed ID: 7925163
[TBL] [Abstract][Full Text] [Related]
20. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.
Johansen TH; Chaudhary A; Verdoorn TA
Mol Pharmacol; 1995 Nov; 48(5):946-55. PubMed ID: 7476926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
